IP Library Patent Application 11794304
Patent Application
App. No. 11/794,304

Sesamin/Episesamin Compositions

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/794,304
Abstract

Sesamin and episesamin are incorporated at specified weight ratios in oral compositions so that the oral absorption of episesamin and/or its transfer into blood circulation is increased. Sesamin and episesamin are also incorporated at specified weight ratios in oral compositions so that the physiological activities of sesamins are enhanced.

Claims (9)

1 : A sesamin/episesamin composition comprising sesamin and episesamin in proportions of 50:50 to 1:99 by weight ratio.

2 : The sesamin/episesamin composition according to claim 1 which comprises sesamin and episesamin in proportions of 39:61 to 1:99 by weight ratio.

3 : The sesamin/episesamin composition according to claim 1 which comprises sesamin and episesamin in proportions of 30:70 to 5:95 by weight ratio.

4 : The sesamin/episesamin composition according to claim 1 , wherein the total amount of sesamin and episesamin is at least 51 wt % of the composition.

5 : Food or beverage containing the sesamin/episesamin composition according to claim 1 .

6 : A pharmaceutical composition containing the sesamin/episesamin composition according to claim 1 .

7 : Animal feed and pet food containing the sesamin/episesamin composition according to claim 1 .

8 : A method of enhancing a physiological activity of sesamins by the sesamin/episesamin composition according to claim 1 .

9 : The method according to claim 8 , wherein the physiological activity of sesamins is a blood cholesterol lowering action, a triglyceride lowering action, an antihypertensive action, an action for antioxidation of unsaturated fatty acids, a hepatic function improving action, an active oxygen scavenging action, an action for inhibiting Δ5 unsaturation enzyme, or an action for in vivo stabilization of highly unsaturated fatty acids.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2009
From: SUNTORY LIMITED
To: SUNTORY HOLDINGS LIMITED
Reel/Frame 022653/0665 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2008
From: ONO, YOSHIKO; TOMIMORI, NAMINO; TOKUDA, SAKI; ROGI, TOMOHIRO
To: SUNTORY LIMITED
Reel/Frame 020834/0378 →